These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship. Li Q; Murphy M; Ross J; Sheehan C; Carlson JA J Cutan Pathol; 2004 Nov; 31(10):633-42. PubMed ID: 15491322 [TBL] [Abstract][Full Text] [Related]
47. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions. Demirkan NC; Kesen Z; Akdag B; Larue L; Delmas V Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395 [TBL] [Abstract][Full Text] [Related]
48. Distribution of muscarinic receptor subtype M3 in melanomas and their metastases. Oppitz M; Busch C; Garbe C; Drews U J Cutan Pathol; 2008 Sep; 35(9):809-15. PubMed ID: 18422974 [TBL] [Abstract][Full Text] [Related]
49. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters. Busam KJ; Iversen K; Berwick M; Spagnoli GC; Old LJ; Jungbluth AA Mod Pathol; 2000 Apr; 13(4):459-65. PubMed ID: 10786815 [TBL] [Abstract][Full Text] [Related]
50. S100A6 protein expression is different in Spitz nevi and melanomas. Ribé A; McNutt NS Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257 [TBL] [Abstract][Full Text] [Related]
52. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma. Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178 [TBL] [Abstract][Full Text] [Related]
53. Mammaglobin, a potential marker of breast cancer nodal metastasis. Leygue E; Snell L; Dotzlaw H; Hole K; Troup S; Hiller-Hitchcock T; Murphy LC; Watson PH J Pathol; 1999 Sep; 189(1):28-33. PubMed ID: 10451484 [TBL] [Abstract][Full Text] [Related]
54. Differential expression of heat shock protein 105 in melanoma and melanocytic naevi. Muchemwa FC; Nakatsura T; Fukushima S; Nishimura Y; Kageshita T; Ihn H Melanoma Res; 2008 Jun; 18(3):166-71. PubMed ID: 18477890 [TBL] [Abstract][Full Text] [Related]
55. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors. Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618 [TBL] [Abstract][Full Text] [Related]
56. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma. Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763 [TBL] [Abstract][Full Text] [Related]